Measles-induced respiratory distress, air-leak and ARDS

  • M. Piastra
  • R. Onesimo
  • D. De Luca
  • L. Lancella
  • L. Marzano
  • G. De Rosa
  • D. Pietrini
  • P. Valentini
  • G. Conti
Article
First Online:
Received:
Accepted:

Abstract

Young infants with measles requiring respiratory support have a significant risk for death and long-term complications. Even in developed countries, the occurrence of spontaneous air-leaks and acute respiratory distress syndrome (ARDS) still represent the most severe clinical presentation in early childhood, with a high fatality rate. A clinical series review from a tertiary university paediatric intensive care unit (PICU) was undertaken. During the 2006–2007 outbreak in Rome, Italy, a young infant presented with ARDS/spontaneous air-leak and needed aggressive ventilatory management and haemodynamic support. Both nebulised iloprost and intravenous pentoxifylline were administered during the acute hypoxaemic phase; the role of this pharmacologic approach in critically ill patients is still under debate. We observed four further cases of respiratory impairment requiring a non-invasive approach. Clinical-radiological findings ranged from interstitial pneumonia to bronchiolitis-like pictures. All patients were imported cases, representing an important epidemiological factor and future medical issue, though they were not malnourished nor affected by chronic diseases. We conclude that early respiratory assessment and timely PICU referral is of mainstem importance in the youngest infants with measles-induced respiratory failure. The protean nature of clinical presentation and the possibility of rapid respiratory deterioration should be highlighted, and infants from immigrant families may represent a susceptible high-risk group.

Keywords

Continuous Positive Airway Pressure Measle Acute Respiratory Distress Syndrome Paediatric Intensive Care Unit Pentoxifylline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Asaria P, MacMahon E (2006) Measles in the United Kingdom: can we eradicate it by 2010? BMJ 333:890–895CrossRefPubMedGoogle Scholar
  2. 2.
    Abramson O, Dagan R, Tal A, Sofer S (1995) Severe complications of measles requiring intensive care in infants and young children. Arch Pediatr Adolesc Med 149:1237–1240PubMedGoogle Scholar
  3. 3.
    Freebeck PC, Clark S, Fahey PJ (1992) Hypoxemic respiratory failure complicating nosocomial measles in a healthy host. Chest 102:625–626CrossRefPubMedGoogle Scholar
  4. 4.
    Rupp ME, Schwartz ML, Bechard DE (1993) Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A. Chest 103:1625–1626CrossRefPubMedGoogle Scholar
  5. 5.
    Filia A, Brenna A, Panà A, Cavallaro GM, Massari M, Ciofi degli Atti ML (2007) Health burden and economic impact of measles-related hospitalizations in Italy in 2002–2003. BMC Public Health 7:169CrossRefPubMedGoogle Scholar
  6. 6.
    Ciofi degli Atti ML, D’Argenio P, di Giorgio G, Filonzi A, Grandori L (2002) Measles in Italy 2002: studies show correlation between vaccine coverage and incidence. EuroSurveill Weekly 6:021205Google Scholar
  7. 7.
    Salmaso S, Rota MC, Ciofi degli Atti ML, Tozzi AE, Kreidl P; ICONA Study Group (1999) Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. Bull World Health Organ 77(10):843–851PubMedGoogle Scholar
  8. 8.
    Filia A, Curtale F, Kreidl P, Morosetti G, Nicoletti L, Perrelli F, Mantovani J, Campus D, Rossi G, Sanna MC, Zanetti A, Magurano F, Fortuna C, Iannazzo S, Pompa MG, Ciofi degli Atti M (2006) Cluster of measles cases in the Roma/Sinti population, Italy, June–September 2006. EuroSurveill Weekly 11(10):E061012.2Google Scholar
  9. 9.
    Swift JD, Barruga MC, Perkin RM, van Stralen D (1993) Respiratory failure complicating rubeola. Chest 104:1786–1787CrossRefPubMedGoogle Scholar
  10. 10.
    McBrien J, Murphy J, Gill D, Cronin M, O’Donovan C, Cafferkey MT (2003) Measles outbreak in Dublin, 2000. Pediatr Infect Dis J 22:580–584CrossRefPubMedGoogle Scholar
  11. 11.
    Turner DA, Arnold JH (2007) Insights in pediatric ventilation: timing of intubation, ventilatory strategies, and weaning. Curr Opin Crit Care 13:57–63CrossRefPubMedGoogle Scholar
  12. 12.
    Harris KW, O’Riordan TG, Smaldone GC (2007) Aerosolized iloprost customized for the critically ill. Respir Care 52(11):1507–1509PubMedGoogle Scholar
  13. 13.
    Kimura A, Kobayashi J, Fawaz M, Masutani S, Nagasaka H, Ohtake A, Sasaki N (2002) Measles pneumonia: treatment of a near-fatal case with nitric oxide inhalation. Pediatr Int 44(4):451–452CrossRefPubMedGoogle Scholar
  14. 14.
    Wiedemann HP, Arroliga AC, Komara JJ Jr (2003) Emerging systemic pharmacologic approaches in acute respiratory distress syndrome. Respir Care Clin N Am 9(4):419–435CrossRefPubMedGoogle Scholar
  15. 15.
    Adhikari N, Burns KE, Meade MO (2004) Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev (4):CD004477Google Scholar
  16. 16.
    Schuster KM, Alouidor R, Barquist ES (2008) Nonventilatory interventions in the acute respiratory distress syndrome. J Intensive Care Med 23:19–32CrossRefPubMedGoogle Scholar
  17. 17.
    Dahlem P, van Aalderen WMC, Bos AP (2007) Pediatric acute lung injury. Paediatr Respir Rev 8:348–362CrossRefPubMedGoogle Scholar
  18. 18.
    Krakauer T (2000) Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. Immunopharmacology 46(3):253–261CrossRefPubMedGoogle Scholar
  19. 19.
    Schermuly RT, Krupnik E, Tenor H, Schudt C, Weissmann N, Rose F, Grimminger F, Seeger W, Walmrath D, Ghofrani HA (2001) Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity. Am J Respir Crit Care Med 164(9):1694–1700PubMedGoogle Scholar
  20. 20.
    Schermuly RT, Leuchte H, Ghofrani HA, Weissmann N, Rose F, Kohstall M, Olschewski H, Schudt C, Grimminger F, Seeger W, Walmrath D (2003) Zardaverine and aerosolised iloprost in a model of acute respiratory failure. Eur Resp J 22:342–347CrossRefGoogle Scholar
  21. 21.
    Thia LP, McKenzie SA, Blyth TP, Minasian CC, Kozlowska WJ, Carr SB (2008) Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis. Arch Dis Child 93(1):45–47CrossRefPubMedGoogle Scholar
  22. 22.
    Essouri S, Chevret L, Durand P, Haas V, Fauroux B, Devictor D (2006) Noninvasive positive pressure ventilation: five years of experience in a pediatric intensive care unit. Pediatr Crit Care Med 7(4):329–334CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • M. Piastra
    • 1
  • R. Onesimo
    • 2
  • D. De Luca
    • 1
  • L. Lancella
    • 3
  • L. Marzano
    • 1
  • G. De Rosa
    • 4
  • D. Pietrini
    • 1
  • P. Valentini
    • 2
  • G. Conti
    • 1
  1. 1.Paediatric Intensive Care Unit“A. Gemelli” Hospital—Catholic UniversityRomeItaly
  2. 2.Paediatric Infectious DiseasesCatholic UniversityRomeItaly
  3. 3.Paediatric Infectious DiseasesBambino Gesù IRCCS Children’s HospitalRomeItaly
  4. 4.Paediatric CardiologyCatholic UniversityRomeItaly

Personalised recommendations